biopharmaceutical

(redirected from biopharmaceuticals)
Also found in: Medical.

bi·o·phar·ma·ceu·ti·cal

 (bī′ō-fär′mə-so͞o′tĭ-kəl)
n.
A drug produced by means of biotechnology, consisting of a large, complex molecule such as a protein rather than a small molecule.
adj.
1. Of or relating to a drug or drugs produced by means of biotechnology: the biopharmaceutical industry.
2. Of or relating to properties of pharmaceutical preparations and their effects after administration: biopharmaceutical factors affecting intestinal absorption of the drug.

biopharmaceutical

(ˌbaɪəʊˌfɑːməˈsjuːtɪkəl)
adj
(Biochemistry) of or relating to drugs produced using biotechnology
Translations

biopharmaceutical

n biológico, biofármaco
References in periodicals archive ?
Boehringer Ingelheim recently inaugurated its commercial production site for biopharmaceuticals in Zhang Jiang Hi-tech Park of Shanghai, China.
The global biopharmaceuticals market is increasing, due to growing aging population.
At the Biberach site, two large-scale facilities for the market launch and cell culture based manufacture of biopharmaceuticals have already been operating successfully for many years.
BioPartners, Baar, Switzerland, a privately-owned biopharmaceuticals company has expressed disappointment that its biosimilar Interferon Alpha, Alpheon(R), had received a negative opinion from the European Medicines Agency's Committee on Medicinal Products for Human Use (CHMP).
WASHINGTON -- The Generic Pharmaceutical Association says "sound science" supports the marketing of generic biopharmaceuticals, and it has called on the Food and Drug Administration to accelerate the approval of affordable biopharmaceuticals.
SEOUL, Korea -- South Korean biotech SK biopharmaceuticals announced yesterday that they entered into a research and development agreement with Medicilon, of Shanghai, China, for their novel new small molecule SKL-PSY that is being developed for the treatment of depression and bipolar disorder.
As consumers are deepening their understanding of types and efficacies of biopharmaceuticals, in vitro diagnostic reagent products are slowly approaching the families, and genetic engineering drugs and antibody drugs are also gradually replacing part of chemical carcinoma drugs with strong side effects, thus greatly benefiting the treatment of cancer patients.
Today more than three hundred biopharmaceuticals have already been approved and many more are in late stage clinical development.
China's demand for Biopharmaceuticals has grown at a fast pace in the past decade.
2 Development History of China's Biopharmaceuticals
The pharmaceutical industry is a sunrise industry, especially biopharmaceuticals, which has just started its large-scale industrialization process.
Biovest is a majority owned subsidiary of Accentia Biopharmaceuticals, Inc.